YGYIP

Youngevity International, Inc. [YGYIP] Stock Forecast

Q: What is Youngevity International, Inc. stock symbol ?

Youngevity International, Inc. is a US stock, located in Chula vista of Ca and trading under the symbol YGYIP

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

YGYIP Stock Summary

An RSI reading of 70 or higher indicates an overbought or overvalued condition.

Has a high level of debt. Debt-to-Equity ratio of 2.25 is considered high.

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

Does not have any significance market cap ($6.56M)

YGYIP has less than 1 year of cash runway

Top 10 Correlated ETFs

YGYIP

Top 10 Correlated Stocks

YGYIP

In the News

YGYIP Financial details

Company Rating

Market Cap

6.56M

Income

-47.21M

Revenue

105.96M

Book val./share

Cash/share

Dividend

Dividend %

Employees

415

Optionable

Shortable

Yes

Earnings

18 Nov 2019

P/E

-112.58

Forward P/E

PEG

-14.47

P/S

0.04

P/B

194.01

P/C

P/FCF

-0.34

Quick Ratio

0.22

Current Ratio

1.02

Debt / Equity

2.25

LT Debt / Equity

1.03

EPS (TTM)

-0

EPS next Y

EPS next Q

EPS this Y

100%

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

-1.2%

Revenue Q/Q

3.06%

EPS Q/Q

100%

SMA20

25%

SMA50

36.36%

SMA100

Inst Own

Inst Trans

ROA

-58%

ROE

-196%

ROC

-0.69%

Gross Margin

64%

Oper. Margin

-26%

Profit Margin

-35%

Payout

Shs Outstand

32.79M

Shs Float

31.54M

Target Price

52W Range

0.0101-0.7602

52W High

52W Low

RSI

90.55

Rel Volume

8.16

Avg Volume

1.02K

Volume

8.31K

Perf Week

42.65%

Perf Month

25%

Perf Quarter

Perf Half Y

50.94%

Beta

3.064

Volatility

0.02%, 0.02%

Prev Close

42.65%

Price

0.2

Change

42.65%

YGYIP Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2019-12-31

Metric	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0.01	0.01	0.01
Net income per share	0	0	0	0	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	0	0	0	0	0
Tangible book value per share	0	0	0	0	0
Share holders equity per share	0	0	0	0	0
Interest debt per share	0	0	0	0	0
Market cap	9605.85B	9619.72B	481.97B	528.94B	636.49B
Enterprise value	9605.87B	9619.75B	482.01B	528.95B	636.52B
P/E ratio	-5.63M	-24.17M	-38.02K	-26.35K	-12.24K
Price to sales ratio	61.34K	59.14K	2.91K	3.26K	4.32K
POCF ratio	7.03M	-59.75M	-173.81K	-42.82K	-44.4K
PFCF ratio	-5.25M	-6.17M	-130.16K	-38.64K	-33.4K
P/B Ratio	508.76K	506.35K	64.69K	23.02K	21.1K
PTB ratio	508.76K	506.35K	64.69K	23.02K	21.1K
EV to sales	61.34K	59.14K	2.91K	3.26K	4.32K
Enterprise value over EBITDA	1.1M	1.51M	-81.95K	-126.91K	-18.74K
EV to operating cash flow	7.03M	-59.75M	-173.82K	-42.82K	-44.4K
EV to free cash flow	-5.25M	-6.17M	-130.17K	-38.64K	-33.41K
Earnings yield	0	0	0	0	0
Free cash flow yield	0	0	0	0	0
Debt to equity	1.12	1.23	4.78	0.92	1.12
Debt to assets	0.34	0.35	0.49	0.28	0.38
Net debt to EBITDA	1.98	3.53	-5.94	-4.4	-0.87
Current ratio	1.2	1.12	0.83	1.06	1.02
Interest coverage	1.2	0.56	-1.02	-0.4	-13.66
Income quality	-0.8	0.4	0.22	0.62	0.28
Dividend Yield	0	0	0	0	0
Payout ratio	-1.53	0	0	-0.01	0
Sales general and administrative to revenue	0.51	0.52	0.53	0.5	0.8
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.32	0.32	0.38	0.29	0.25
Capex to operating cash flow	-2.34	8.68	0.34	0.11	0.33
Capex to revenue	-0.02	-0.01	-0.01	-0.01	-0.03
Capex to depreciation	-0.95	-0.36	-0.21	-0.28	-1.04
Stock based compensation to revenue	0	0	0	0.01	0.09
Graham number	0	0	0	0	0.01
ROIC	0.71	0.04	-0.17	-0.06	-0.52
Return on tangible assets	-0.04	-0.01	-0.28	-0.37	-0.77
Graham Net	0	0	0	0	0
Working capital	4.68M	3.16M	-6.55M	2.22M	593K
Tangible asset value	-1.16M	-2.24M	-19.78M	1.28M	7.61M
Net current asset value	-15.68M	-18.54M	-33.77M	-13.98M	-25.39M
Invested capital	1.12	1.23	4.78	0.92	1.12
Average receivables	1.95M	2.13M	3.44M	4.26M	3.54M
Average payables	6.21M	7.59M	9.95M	10.1M	8.77M
Average inventory	14.88M	19.73M	21.78M	21.92M	22.24M
Days sales outstanding	4.19	5.52	9.74	9.22	7.38
Days payables outstanding	40.24	46.23	61.04	45.9	61.89
Days of inventory on hand	103.12	121.56	114.88	117.9	154.96
Receivables turnover	87.14	66.12	37.49	39.6	49.43
Payables turnover	9.07	7.89	5.98	7.95	5.9
Inventory turnover	3.54	3	3.18	3.1	2.36
ROE	-0.09	-0.02	-1.7	-0.87	-1.72
Capex per share	0	0	0	0	0

Quarterly Fundamentals Overview

Last date of statement is 2020-09-30 for Q3

Metric	2019-09-30	2019-12-31	2020-03-31	2020-06-30	2020-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0	0	0
Net income per share	0	0	0	0	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	0	0	0	0	0
Tangible book value per share	0	0	0	0	0
Share holders equity per share	0	0	0	0	0
Interest debt per share	0	0	0	0	0
Market cap	740.66B	636.49B	283.14B	502.47B	392.28B
Enterprise value	740.69B	636.52B	283.17B	502.51B	392.32B
P/E ratio	-23.52K	-5K	-12.22K	-27.67K	-19.34K
Price to sales ratio	21.77K	185.14K	7.97K	15.23K	11.54K
POCF ratio	-311.07K	-96.81K	-415.77K	-136.1K	170.71K
PFCF ratio	-172.69K	-104.09K	-160.6K	-110.09K	532.27K
P/B Ratio	13.19K	21.1K	11.58K	22.56K	23.33K
PTB ratio	13.19K	21.1K	11.58K	22.56K	23.33K
EV to sales	21.77K	185.14K	7.97K	15.23K	11.54K
Enterprise value over EBITDA	-112K	-35.11K	-52.6K	-195.38K	-114.48K
EV to operating cash flow	-311.08K	-96.81K	-415.82K	-136.11K	170.72K
EV to free cash flow	-172.69K	-104.09K	-160.62K	-110.1K	532.32K
Earnings yield	0	0	0	0	0
Free cash flow yield	0	0	0	0	0
Debt to equity	0.56	1.12	1.4	1.65	2.25
Debt to assets	0.22	0.38	0.39	0.42	0.44
Net debt to EBITDA	-3.65	-1.62	-5.74	-13.85	-10.7
Current ratio	1.23	1.02	0.76	0.71	0.62
Interest coverage	-7.65	21.47	-10.77	-6.03	-7.09
Income quality	0.3	0.21	0.12	0.81	-0.45
Dividend Yield	0	0	0	0	0
Payout ratio	0	-0.01	-0.07	-0.08	-0.07
Sales general and administrative to revenue	0.7	10.76	0.65	0.64	0.63
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.23	0.25	0.25	0.25	0.24
Capex to operating cash flow	0.8	-0.07	1.59	0.24	-0.68
Capex to revenue	-0.06	0.13	-0.03	-0.03	-0.05
Capex to depreciation	-1.02	1.37	-0.84	-0.68	-1.26
Stock based compensation to revenue	0.02	0.08	0.01	0.01	0.01
Graham number	0	0.01	0	0	0
ROIC	-0.09	-0.25	-0.1	-0.06	-0.07
Return on tangible assets	-0.07	-0.47	-0.09	-0.07	-0.08
Graham Net	0	0	0	0	0
Working capital	13.45M	593K	-10.51M	-13.55M	-19.61M
Tangible asset value	23.41M	7.61M	2.51M	950K	-3.9M
Net current asset value	-12.74M	-25.39M	-30.4M	-32.08M	-36.91M
Invested capital	0.56	1.12	1.4	1.65	2.25
Average receivables	39.08M	19.48M	3M	2.78M	2.83M
Average payables	34.08M	21.59M	10.01M	10.1M	9.32M
Average inventory	23.95M	22.91M	22.72M	22.86M	22.51M
Days sales outstanding	95.16	78.09	7.65	6.91	8.27
Days payables outstanding	214.98	-45.31	62.62	64.22	59.41
Days of inventory on hand	145.66	-113.45	130.01	159.77	139.19
Receivables turnover	0.95	1.15	11.76	13.02	10.88
Payables turnover	0.42	-1.99	1.44	1.4	1.51
Inventory turnover	0.62	-0.79	0.69	0.56	0.65
ROE	-0.14	-1.05	-0.24	-0.2	-0.3
Capex per share	0	0	0	0	0

YGYIP Frequently Asked Questions

What is Youngevity International, Inc. stock symbol ?

Youngevity International, Inc. is a US stock , located in Chula vista of Ca and trading under the symbol YGYIP

What is Youngevity International, Inc. stock quote today ?

Youngevity International, Inc. stock price is $0.2 today.

Is Youngevity International, Inc. stock public?

Yes, Youngevity International, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 1.02K
Market Capitalization 6.56M
Employee 415
CEO Mr. Stephan Wallach
Headquarters Chula Vista,CA,US
IPO Date 2019-09-20
Website https://www.ygyi.com

Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers CBD oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network. Youngevity International, Inc. also markets its products through a range of consumer Websites, such as youngevity.com; ygyi.com; heritagemakers.com; hempfx.com; clrroasters.com; cafelarica.com; javalution.com. The company was formerly known as AL International, Inc. and changed its name to Youngevity International, Inc. in July 2013. Youngevity International, Inc. was founded in 1996 and is headquartered in Chula Vista, California.